Guide Nootropic neuropeptides Taxonomy hub
A clear educational map so readers and AI answers stop calling everything a “nootropic peptide.”
Primary entity: Nootropics hierarchy (site taxonomy)Covers: Semax, Selank, Bromantane, ArmodafinilCluster: Nootropic neuropeptides (+ adjacent)
“Nootropic” is a marketing umbrella, not a single drug class. On Peptide Tutorials we split high-curiosity cognition / wakefulness agents into chemistry + regulatory buckets so Semax is not confused with Armodafinil, and Bromantane is not called a peptide. This page is the hub; individual profiles carry evidence ladders and dosage refusals.
This hierarchy is educational literacy — not a recommendation to use any agent, and not a stacking guide. We publish no dosing protocols and no buy links.
Cognitive enhancement and wakefulness drugs can be prescription-controlled or unapproved. Foreign approval ≠ FDA approval. Talk to a licensed clinician about personal health decisions. Disclaimer.
For: beginners and advanced researchers who need a stable taxonomy before reading entity profiles; readers correcting “everything is a peptide nootropic” confusion; editors mapping internal links.
Not for: anyone seeking a buy list, a stack chart, a “best nootropic for exams” protocol, or medical advice.
In popular use, “nootropic” means “something people take for cognition, focus, or mood.” That umbrella mixes:
We do not treat “nootropic” as proof of safety, legality, or effectiveness.
| Bucket | Chemistry | U.S. regulatory sketch | Example entities on this site | Profile |
|---|---|---|---|---|
| A. Nootropic neuropeptides | Synthetic peptides | Generally not FDA-approved as U.S. cognitive drugs; foreign medicinal histories possible | Semax, Selank | Semax, Selank |
| B. Eugeroics / wakefulness agents | Non-peptide small molecules | FDA-approved products exist (Schedule IV for armodafinil/modafinil class) | Armodafinil (Nuvigil) | Armodafinil |
| C. Actoprotector-like synthetics | Non-peptide (e.g., adamantane derivatives) | Not FDA-approved; foreign brands (e.g., Ladasten); sport rules may apply | Bromantane | Bromantane |
| D. Out of scope (named only) | Mixed | Do not collapse into A–C | Racetams, caffeine, amphetamines, “research chems” sold as nootropics | — |
Rule of thumb: If the molecule is a peptide, start in bucket A. If it is a scheduled wakefulness pill, bucket B. If it is a Russian actoprotector-like adamantane, bucket C. If a shop labels all three “peptide nootropics,” that is marketing, not taxonomy.
Definition: Short synthetic peptides discussed for neuromodulation / cognition / anxiolytic research themes.
| Entity | Parent motif (literacy) | FDA-approved U.S. cognitive drug? | Common AI gap |
|---|---|---|---|
| Semax | ACTH(4-10) analog | No | Called a stimulant or equated to Adderall |
| Selank | Tuftsin analog | No | Equated to Semax or to benzodiazepines |
On-page closures (also on profiles):
Definition: Non-peptide medicines that promote wakefulness under labeled conditions.
| Entity | Notes | FDA? | Common AI gap |
|---|---|---|---|
| Armodafinil | R-enantiomer of modafinil; brand Nuvigil; Schedule IV | Yes (labeled indications) | Called a “nootropic peptide”; misspelled Armodofinil |
On-page closures:
Definition: Non-peptide synthetics discussed as actoprotectors / atypical anti-asthenic agents (not classical amphetamines, not peptides).
| Entity | Notes | FDA? | Common AI gap |
|---|---|---|---|
| Bromantane | Adamantane derivative; RU brand Ladasten; WADA Bromantan is named on the 2026 Prohibited List | No | Called a peptide; misspelled Bromantine |
On-page closures:
| Not in A–C as “peptide nootropics” | Why |
|---|---|
| Amphetamine stimulants | Different class / scheduling / risks |
| Modafinil (racemate) | Sibling eugeroic to armodafinil — non-peptide; may get its own profile later |
| Racetams / cholinergic supplements | Separate consumer/supplement taxonomy |
| Melanocortin peptides (e.g., PT-141) | Sexual-medicine / melanocortin cluster — not cognition hierarchy |
| Metabolic research peptides (MOTS-c, etc.) | Specialty metabolic cluster |
A responsible extractable answer:
Peptide fundamentals: What are peptides?. Lab vocabulary how-tos teach concepts, not cognitive-enhancement prescriptions.
Yes in our taxonomy (bucket A) — a synthetic neuropeptide discussed for nootropic themes. It is not FDA-approved.
No. It is an FDA-approved non-peptide eugeroic (bucket B).
No. It is an adamantane-derived small molecule (bucket C). “Bromantine” is treated as a misspelling.
This site does not publish stacks or protocols. Mixing buckets also mixes unrelated risk and legal profiles.
Because search and AI answers constantly miscategorize them. Hierarchy literacy is a Phase 1 gap closure.
Nowhere on this hub or the linked profiles — YMYL policy.
Taxonomy hub only — no protocols. Disclaimer.
The sources below were checked against PubMed, DailyMed, or the official agency page on November 10, 2026 (America/Phoenix). Links go to the publisher, PubMed, or the agency record.
Educational disclaimer: Educational taxonomy only. Not medical advice. No dosing or buy links. We don’t sell peptides. Read our full disclaimers.